CL2011001939A1 - Uso de lactobacillus helveticus cncm i-4095 para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales, particularmente para tratar la obesidad y trastornos metabólicos; y microorganismo de la cepa de lactobacillus helveticus cncm i-4095. - Google Patents
Uso de lactobacillus helveticus cncm i-4095 para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales, particularmente para tratar la obesidad y trastornos metabólicos; y microorganismo de la cepa de lactobacillus helveticus cncm i-4095.Info
- Publication number
- CL2011001939A1 CL2011001939A1 CL2011001939A CL2011001939A CL2011001939A1 CL 2011001939 A1 CL2011001939 A1 CL 2011001939A1 CL 2011001939 A CL2011001939 A CL 2011001939A CL 2011001939 A CL2011001939 A CL 2011001939A CL 2011001939 A1 CL2011001939 A1 CL 2011001939A1
- Authority
- CL
- Chile
- Prior art keywords
- lactobacillus helveticus
- helveticus cncm
- microorganism
- humans
- animals
- Prior art date
Links
- 240000002605 Lactobacillus helveticus Species 0.000 title abstract 4
- 235000013967 Lactobacillus helveticus Nutrition 0.000 title abstract 4
- 229940054346 lactobacillus helveticus Drugs 0.000 title abstract 4
- 241001465754 Metazoa Species 0.000 title abstract 2
- 238000012423 maintenance Methods 0.000 title abstract 2
- 244000005700 microbiome Species 0.000 title abstract 2
- 230000004580 weight loss Effects 0.000 title abstract 2
- 208000008589 Obesity Diseases 0.000 title 1
- 208000030159 metabolic disease Diseases 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 abstract 2
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 abstract 1
- 238000004690 coupled electron pair approximation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
USO DE LACTOBACILLUS HELVETICUS CNCM 1-4095 PARA APOYAR LA PERDIDA DE PESO Y/O MANTENIMIENTO DEL PESO EN HUMANOS Y/O ANIMALES Y MICROORGANISMO DE LA CEPA LACTOBACILLUS HELVETICUS DEPOSITADO BAJO EL NÚMERO DE ACCESO CNCM 1-4095.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09152434A EP2216034A1 (en) | 2009-02-10 | 2009-02-10 | Lactobacillus helveticus CNCM I-4095 and weight control |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011001939A1 true CL2011001939A1 (es) | 2012-01-20 |
Family
ID=40749130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011001939A CL2011001939A1 (es) | 2009-02-10 | 2011-08-10 | Uso de lactobacillus helveticus cncm i-4095 para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales, particularmente para tratar la obesidad y trastornos metabólicos; y microorganismo de la cepa de lactobacillus helveticus cncm i-4095. |
Country Status (8)
Country | Link |
---|---|
US (1) | US8454949B2 (es) |
EP (2) | EP2216034A1 (es) |
CN (1) | CN102316882B (es) |
AU (1) | AU2010213007B2 (es) |
BR (1) | BRPI1008355A2 (es) |
CL (1) | CL2011001939A1 (es) |
MX (1) | MX2011008398A (es) |
WO (1) | WO2010091991A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2216034A1 (en) * | 2009-02-10 | 2010-08-11 | Nestec S.A. | Lactobacillus helveticus CNCM I-4095 and weight control |
RU2453593C1 (ru) * | 2011-04-21 | 2012-06-20 | Общество с ограниченной ответственностью "Бифилюкс" | Штамм lactobacillus helveticus, используемый для получения продукции, содержащей лактобактерии |
CN102329762A (zh) * | 2011-11-01 | 2012-01-25 | 内蒙古农业大学 | 一种瑞士乳杆菌h9及其用途 |
CN102329763A (zh) * | 2011-11-01 | 2012-01-25 | 内蒙古农业大学 | 一种瑞士乳杆菌h9及其在制备发酵乳中的用途 |
CN109172816A (zh) | 2012-03-29 | 2019-01-11 | 塞拉拜姆有限责任公司 | 在回肠和阑尾上有活性的胃肠位点特异性口服接种疫苗制剂 |
AU2014239883B2 (en) | 2013-03-14 | 2019-01-17 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
US9518975B2 (en) * | 2013-03-28 | 2016-12-13 | Nestec S.A. | Alpha-keto-isovalerate as a biomarker of prebiotic efficacy for weight gain prevention |
CN104771416B (zh) * | 2014-01-10 | 2020-11-10 | 景岳生物科技股份有限公司 | 用于控制体重的罗伊氏乳杆菌gmnl-263组合物及其用途 |
KR102125548B1 (ko) | 2015-02-10 | 2020-06-24 | 주식회사 지니스 | 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물 |
WO2018136884A1 (en) * | 2017-01-23 | 2018-07-26 | The Regents Of The University Of California | Compositions and methods for treating obesity and inducing weight loss |
CN109112083B (zh) * | 2018-08-01 | 2020-08-04 | 江南大学 | 一种高产辛酸的瑞士乳杆菌及其应用 |
TWI713972B (zh) * | 2019-01-14 | 2020-12-21 | 大江生醫股份有限公司 | 改善呼吸道健康之益生菌株及其組合物與用途 |
KR102495246B1 (ko) * | 2022-08-02 | 2023-02-14 | (주)헥토헬스케어 | 체지방 감소 활성을 갖는 락토바실러스 헬베티쿠스 bcc-lh-04 및 이를 포함하는 조성물 |
CN117757702A (zh) * | 2024-02-21 | 2024-03-26 | 中科微智(北京)生物科技有限公司 | 瑞士乳杆菌、可食用添加剂、食品、药物、饲料以及该菌的应用和方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002071874A2 (en) * | 2001-03-09 | 2002-09-19 | Societe Des Produits Nestle S.A. | Composition improving age-related physiological deficits and increasing longevity |
ITMI20020399A1 (it) * | 2002-02-28 | 2003-08-28 | Ct Sperimentale Del Latte S P | Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici |
EP1344458A1 (en) * | 2002-03-12 | 2003-09-17 | Société des Produits Nestlé S.A. | Probiotic delivery system |
EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
EP1388295A1 (en) * | 2002-08-07 | 2004-02-11 | Nestec S.A. | Cereal based food product comprising DHA |
DE602006004956D1 (de) | 2006-02-20 | 2009-03-12 | Gervais Danone Sa | Neue Stämme von Lactobacillus helveticus |
JP2007284360A (ja) | 2006-04-13 | 2007-11-01 | Mitsukan Group Honsha:Kk | 乳酸菌由来のppar依存的遺伝子転写活性化組成物 |
NZ575469A (en) | 2006-09-04 | 2012-05-25 | Megmilk Snow Brand Co Ltd | Agent comprising lactobacillus for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor |
EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
EP2216034A1 (en) * | 2009-02-10 | 2010-08-11 | Nestec S.A. | Lactobacillus helveticus CNCM I-4095 and weight control |
-
2009
- 2009-02-10 EP EP09152434A patent/EP2216034A1/en not_active Withdrawn
-
2010
- 2010-02-04 MX MX2011008398A patent/MX2011008398A/es active IP Right Grant
- 2010-02-04 CN CN201080007306XA patent/CN102316882B/zh not_active Expired - Fee Related
- 2010-02-04 BR BRPI1008355A patent/BRPI1008355A2/pt not_active IP Right Cessation
- 2010-02-04 US US13/147,687 patent/US8454949B2/en not_active Expired - Fee Related
- 2010-02-04 EP EP10702320A patent/EP2396013A1/en not_active Withdrawn
- 2010-02-04 WO PCT/EP2010/051360 patent/WO2010091991A1/en active Application Filing
- 2010-02-04 AU AU2010213007A patent/AU2010213007B2/en not_active Ceased
-
2011
- 2011-08-10 CL CL2011001939A patent/CL2011001939A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN102316882B (zh) | 2013-09-18 |
EP2396013A1 (en) | 2011-12-21 |
CN102316882A (zh) | 2012-01-11 |
BRPI1008355A2 (pt) | 2016-02-23 |
AU2010213007B2 (en) | 2014-08-07 |
WO2010091991A1 (en) | 2010-08-19 |
EP2216034A1 (en) | 2010-08-11 |
AU2010213007A1 (en) | 2011-08-25 |
US20110293568A1 (en) | 2011-12-01 |
MX2011008398A (es) | 2011-09-01 |
US8454949B2 (en) | 2013-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011001939A1 (es) | Uso de lactobacillus helveticus cncm i-4095 para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales, particularmente para tratar la obesidad y trastornos metabólicos; y microorganismo de la cepa de lactobacillus helveticus cncm i-4095. | |
CL2011001937A1 (es) | Uso de la cepa de lactobacillus rhamnosus cncm i-4096 para apoyar la pérdida de peso y/o mantenimiento del peso en humanos y/o animales, específicamente para el tratamiento de la obesidad. | |
ES2561253T3 (es) | Bacterias probióticas que tienen actividad antioxidante y uso de las mismas | |
ES2524432T3 (es) | Bacterias del ácido láctico como cepas probióticas y composiciones que contienen las mismas | |
CL2012001950A1 (es) | Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño | |
CL2009000905A1 (es) | Composicion comestible que comprende bifidobacterium longum atcc baa-999; y su uso para tratar o prevenir la ansiedad y/o desordenes relacionados con ansiedad. | |
IN2012DN02463A (es) | ||
ATE537707T1 (de) | Lactobacillus paracasei und gewichtskontrolle | |
BR112015025256A8 (pt) | Cepas probióticas para uso no tratamento ou prevenção da osteoporose | |
CL2012000869A1 (es) | Composicion que comprende cepa seleccionada de lactobacillus plantarum cect 7527, o cepas mutantes de la misma; uso de una composicion para prevenir y/o tratar transtornos cardiovasculares. | |
CO6440531A2 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
ES2531193T3 (es) | Cepas de levadura y métodos de utilización de las mismas | |
MX2011008399A (es) | Lactobacillus rhamnosus ncc4007, una mezcla probiotica y el control del peso. | |
AR094025A1 (es) | Utilizacion de bifidobacterium animalis para el tratamiento o la prevencion de la ganancia de peso corporal y de la resistencia a la insulina | |
PH12015500091B1 (en) | Non-pathogenic f18 e.coli strain and use thereof | |
RS54837B1 (sr) | Upotreba streptococcus salivarius u lečenju hroničnih infekcija respiratornog trakta | |
AR093426A1 (es) | Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo | |
UA113399C2 (xx) | Штам непатогенної грамнегативної бактерії та його застосування в дерматології | |
AR093425A1 (es) | Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal | |
EA201291440A1 (ru) | Пробиотические штаммы для применения при повышении трансэпителиального сопротивления | |
FR3007655B1 (fr) | Souche bacillus subtilis pour le traitement et/ou la prevention de maladies inflammatoires chroniques | |
CL2012000012A1 (es) | Bifidobacterium longum con número de depósito ncc2916; composición que lo comprende; uso de dicho bifidobacterium para aumentar el número de bacterias probióticas vivas en un producto. | |
PL410460A1 (pl) | Biopreparat do konserwowania surowców odnawialnych przeznaczonych do produkcji biogazu | |
RU2012108361A (ru) | Штамм лактозосбраживающих бактерий enterococcus hirae вкпм в-9069 - продуцент молочной кислоты и пробиотиков | |
RU2009116228A (ru) | Штамм бактерий bacillius sp. м3-реликтовые микроорганизмы, стимулирующие деятельность иммунной системы и увеличивающие продолжительность жизни |